Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
Hanmeng Liu, Wei Shen, Wanguo Liu, et al.
Bioactive Materials (2023) Vol. 31, pp. 206-230
Open Access | Times Cited: 23

Showing 23 citing articles:

Membrane-anchoring clickable Iridium(III) nanosonosensitizer in situ evokes PANoptosis for augmented tumor sono-immunotherapy
Xiaoyu Xu, Shayibai Shabiti, Xu Zhang, et al.
Nano Today (2024) Vol. 56, pp. 102270-102270
Closed Access | Times Cited: 13
Three Rounds of Stability-Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX-315
Xing‐Yan Fu, Hao Yin, Xi‐Tong Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3885-3908
Closed Access | Times Cited: 7
Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer
Lili Niu, Yao Liu, Nannan Li, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123810-123810
Closed Access | Times Cited: 3
ACP-DRL: an anticancer peptides recognition method based on deep representation learning
Xiaofang Xu, Chaoran Li, Xinpu Yuan, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 3
Synthesis and structural optimization of oncolytic peptide LTX-315
Min Song, Qing Liu, Jing-Fang Yao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 107, pp. 117760-117760
Closed Access | Times Cited: 2
Scaffolds of Chitosan-metallic hybrids as antimicrobial wound dressing
Shengyu Zhang, Muhammad Ali, Farooq Nawaz, et al.
Journal of Molecular Liquids (2024), pp. 126541-126541
Closed Access | Times Cited: 2
Enzyme-responsive oncolytic polypeptide for tumor therapy
Renyong Yin, Penqi Wan, Zhihui Guo, et al.
Acta Biomaterialia (2024) Vol. 181, pp. 415-424
Closed Access | Times Cited: 1
Allogeneic “Zombie Cell” as Off‐The‐Shelf Vaccine for Postsurgical Cancer Immunotherapy
Bo Li, Ping Zhang, Junlin Li, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 1
The role of FHL1 in tumors
Qun Zeng, Tingting Jiang
Gene (2024) Vol. 911, pp. 148347-148347
Closed Access | Times Cited: 1
In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy
Shuyan Han, Zixuan Zhao, Jun Wu
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Polysulfonium: Unveiling a Bioactive Polymer to Induce Immunogenic Cell Death for Anticancer Therapy
Xueli Lv, Renyong Yin, Min Lin, et al.
Nano Letters (2024) Vol. 24, Iss. 34, pp. 10664-10673
Closed Access | Times Cited: 1
Dual and multi-immune activation strategies for emerging cancer immunotherapy
Ying Zhang, Liang Liu, Huilan He, et al.
Materials Today (2024)
Closed Access | Times Cited: 1
Cost-Effective Synthesis, Stability-Guided Structural Optimization and Anticancer Evaluation of First-in-Class Oncolytic Peptide Ltx-315
Min Song, Qing Liu, Jing-Fang Yao, et al.
(2024)
Closed Access
Rational design of a new short anticancer peptide with good potential for cancer treatment
Xiaoyan Wu, Yali Tian, Kaixin Ran, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116519-116519
Closed Access
ANTICANCER IMMUNOGENIC POTENTIAL OF ONCOLYTIC PEPTIDES: RECENT ADVANCES AND NEW PROSPECTS
N. Khranovska, O. Skachkova, О. Gorbach, et al.
Experimental Oncology (2024) Vol. 46, Iss. 1, pp. 3-12
Open Access
Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors
Ana Paula de Araújo Boleti, Ana Cristina Jacobowski, Tamaeh Monteiro‐Alfredo, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3891-3891
Open Access
Branched Oncolytic Peptides Target HSPGs, Inhibit Metastasis, and Trigger the Release of Molecular Determinants of Immunogenic Cell Death in Pancreatic Cancer.
Alessandro Rencinai, Eva Tollapi, Giulia Marianantoni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
PEGylation Can Effectively Strike a Balance in siRNA Delivery Performances of Guanidinylated Linear Synthetic Polypeptides with Potential Use for Transcriptional Gene Silencing
Xujun Lu, Jiajian Qiu, Yilan Li, et al.
ACS Macro Letters (2024), pp. 1251-1257
Closed Access
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer
Alessandro Rencinai, Eva Tollapi, Giulia Marianantoni, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Tumor Microenvironment-Activated Polypeptide Nanoparticles for Oncolytic Immunotherapy
Zhihui Guo, Tianze Huang, Xueli Lv, et al.
Biomaterials (2024) Vol. 314, pp. 122870-122870
Closed Access
Host Defense Peptides: Exploiting an Innate Immune Component Against Infectious Diseases and Cancer
Taiwo Scholes Adewole, Oladiran Boniface Oladokun, Adenike Kuku
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 6
Closed Access
pH-Ultrasensitive Membranolytic Polyesters with Alternating Sequence of Ionizable and Hydrophobic Groups for Selective Oncolytic Therapy
Jihong Wang, Yueling Yuan, Chanjuan Su, et al.
Journal of the American Chemical Society (2024) Vol. 147, Iss. 1, pp. 1008-1016
Closed Access
Comprehensive pan‑cancer analysis of potassium voltage-gated channel Q4 (KCNQ4) gene across multiple human malignant tumors
Qing Zhao, Meizeng Li, Yunxiang Zhang
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Page 1

Scroll to top